Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
To show that the use of intravenous levetiracetam(LEV;Keppra)for seizure prevention in
patients in the Neuroscience Intensive Care Unit will result in fewer side effects compared
to the current standard of care anticonvulsant and will be at least as effective as the
current standard of care in preventing clinical and sub-clinical seizure activity.